Connor, Clark & Lunn Investment Management (CC&L)’s Prothena Corp PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
RCMNY
ACM
PAI
Connor, Clark & Lunn Investment Management (CC&L)'s PRTA Position: Q2 2026 in Review
Connor, Clark & Lunn Investment Management (CC&L) increased its Prothena Corp (PRTA) stake by 22% in Q2 2026, buying an estimated $347K and bringing the position to 191,693 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1022.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PRTA in Q3 2014 and has held it in 26 quarters since. The position peaked at $7.52M in Q2 2023. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) held 191,693 shares of Prothena Corp worth $1.88M as of Q2 2026.
- Connor, Clark & Lunn Investment Management (CC&L) bought 35,142 Prothena Corp shares in Q2 2026, an estimated $347K.
- Prothena Corp made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1022 holding.
- Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Prothena Corp in Q3 2014 and has held it in 26 quarters since.
- Connor, Clark & Lunn Investment Management (CC&L)'s Prothena Corp position peaked at $7.52M in Q2 2023.
- 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.